Article

Development and Clinical Evaluation of a Rapid Antibody Lateral Flow Assay for the Diagnosis of SARS-CoV-2 Infection

2020-10-26

Abstract excerpt

<h4>Background: </h4> The novel coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has quickly spread worldwide since its outbreak in December 2019. One of the primary measures for controlling the spread of SARS-CoV-2 infection is an accurate assay for its diagnosis. SARS-CoV-2 real-time PCR kits suffer from some limitations, i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9df6a846-7e41-5aca-9587-4c458173e4e8
DOI: 10.21203/rs.3.rs-94508/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development and Clinical Evaluation of a Rapid Antibody Lateral Flow Assay for the Diagnosis of SARS-CoV-2 InfectionDOI 10.21203/rs.3.rs-94508/v1Read

Evaluation of Nucleocapsid and Spike Protein-based ELISAs for detecting antibodies against SARS-CoV-2Semantic proximity Read

Comparison of a prototype SARS-CoV-2 lateral flow immunoassay with the BinaxNOW™ COVID-19 Antigen CARDSemantic proximity Read

Exploratory study of antibody titers against SARS-CoV-2 using an indirect immunoperoxidase assay in COVID-19 patients and vaccinated volunteersSemantic proximity Read

Screening and confirmation tests for SARS-CoV-2: benefits and drawbacksSemantic proximity Read

Rapid lateral flow immunoassay for the fluorescence detection of SARS-CoV-2 RNASemantic proximity Read

Clinical and experimental factors that affect the reported performance characteristics of rapid testing for SARS-CoV-2Semantic proximity Read

A comparative review of immunoassays for COVID-19 detectionSemantic proximity Read

Accuracy of Rapid Point-of-Care Antibody Test in patients with suspected or confirmed COVID-19Semantic proximity Read

Novel Lateral Flow-Based Assay for Simple and Visual Detection of SARS-CoV-2 Mutations.Semantic proximity Read

Diagnostic accuracy of two commercially available rapid assays for detection of IgG and IgM antibodies to SARS-CoV-2 compared to ELISA in a low-prevalence populationSemantic proximity Read

The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In VitroSemantic proximity Read

Evaluation of a Rapid Semiquantitative Lateral Flow Assay for the Prediction of Serum Neutralizing Activity Against SARS-CoV-2 VariantsSemantic proximity Read